Ratios for ANEB - findataslice

Ratios for ANEB - findataslice

Anebulo Pharmaceuticals, Inc.

Q4-CY2025

Q3-CY2025

Q2-CY2025

Q1-CY2025

Q4-CY2024

Q3-CY2024

Q2-CY2024

Q1-CY2024

Q4-CY2023

Q3-CY2023

Q2-CY2023

Q1-CY2023

Q4-CY2022

Q3-CY2022

Q2-CY2022

Q1-CY2022

Q4-CY2021

Q3-CY2021

Q2-CY2021

Q1-CY2021

Q4-CY2020

Q3-CY2020

Q2-CY2020

Q1-CY2020

Q4-CY2019

Q3-CY2019

Q2-CY2019

Q1-CY2019

Q4-CY2018

Q3-CY2018

Q2-CY2018

Q1-CY2018

Q4-CY2017

Q3-CY2017

Q2-CY2017

Q1-CY2017

Q4-CY2016

Q3-CY2016

Q2-CY2016

Q1-CY2016

Q4-CY2015

Q3-CY2015

Q2-CY2015

Q1-CY2015

Q4-CY2014

Q3-CY2014

Q2-CY2014

Q1-CY2014

Q4-CY2013

Balance Sheet Date

2025-Jun-30

2025-Mar-31

2024-Dec-31

2024-Sep-30

2024-Jun-30

2024-Mar-31

2023-Dec-31

2023-Sep-30

2023-Jun-30

2023-Mar-31

2022-Dec-31

2022-Sep-30

2022-Jun-30

2022-Mar-31

2021-Dec-31

2021-Sep-30

2021-Mar-31

Fiscal Period

Q4-FY2025

Q3-FY2025

Q2-FY2025

Q1-FY2025

Q4-FY2024

Q3-FY2024

Q2-FY2024

Q1-FY2024

Q4-FY2023

Q3-FY2023

Q2-FY2023

Q1-FY2023

Q4-FY2022

Q3-FY2022

Q2-FY2022

Q1-FY2021

Q3-FY2020

Price to Sales

Forward Price to Sales MRQ

Price to Book

8.07x

8.35x

5.22x

4.12x

2.98x

26.22x

18.23x

15.14x

10.04x

9.81x

6.00x

5.70x

4.01x

3.80x

7.31x

8.17x

7.79x

8.23x

Price to Earnings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Forward Price to Earnings MRQ

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt to Asset Ratio

.04x

.04x

.06x

.23x

.06x

.17x

.14x

.08x

.09x

.10x

.08x

.04x

.03x

-

-

.03x

2.51x

.07x

Current Ratio

13.30x

13.53x